간행물

대한내과학회> 대한내과학회지 (Korean J Med)

대한내과학회지 (Korean J Med) update

The Korean Journal of Medicine (Korean J Med)

  • : 대한내과학회
  • : 의약학분야  >  내과학
  • : KCI후보
  • :
  • : 연속간행물
  • : 격월
  • : 1738-9364
  • : 2289-0769
  • : 대한내과학회잡지(~1992) → 대한내과학회지(1993~) → korean journal of medicine(1996~)

수록정보
97권3호(2022) |수록논문 수 : 7
간행물 제목
97권6호(2022년 12월) 수록논문
최근 권호 논문
| | | |

KCI후보

저자 : 박중원 ( Jung-won Park )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 6호 발행 연도 : 2022 페이지 : pp. 335-338 (4 pages)

다운로드

(기관인증 필요)

초록보기

Since its establishment in 1945, the Korean Association of Internal Medicine (KAIM) has had a proud history of overcoming challenges with the combined and harmonized endeavors of all KAIM members. KAIM is now facing several issues related to marked social changes in Korea as well as revolutions in medical science and scientific and communications technologies. Furthermore, KAIM shortened the resident training program in 2017. Internal medicine (IM) is an essential discipline for maintaining and improving the health of Korean citizens. However, the Korean Ministry of Health and Welfare lacks initiatives for supporting IM, and the Korean Health Insurance reimbursement policy does not reflect the essential role of IM in health care. This is aggravated by imbalances in hospital resources and skewed notions in patients' preferences with regard to metropolitan and non-metropolitan areas. Limited preferences in application to subspecialties may be an obstacle for coordinated development of IM. The current generations of students and residents are familiar with online educational lectures and have different needs for educational materials, which are not met by conventional educational materials. Recent experiences in the COVID-19 pandemic have exacerbated or accelerated these changes and problems. From this perspective, I will summarize the challenges that KAIM is now facing, and outline some possible solutions. (Korean J Med 2022;97:335-338)

KCI후보

저자 : 이찬주 ( Chan Joo Lee ) , 윤민재 ( Minjae Yoon ) , 강현재 ( Hyun-jae Kang ) , 김병진 ( Byung Jin Kim ) , 최성희 ( Sung Hee Choi ) , 정인경 ( In-kyung Jeong ) , 이상학 ( Sang-hak Lee )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 6호 발행 연도 : 2022 페이지 : pp. 339-352 (14 pages)

다운로드

(기관인증 필요)

초록보기

Familial hypercholesterolemia (FH) is the most common monogenic disorder. Due to the marked elevation of cardiovascular risk, the early detection, diagnosis, and proper management of this disorder are critical. Herein, the 2022 Korean guidance on this disease is presented. Clinical features include severely elevated low-density lipoprotein cholesterol (LDL-C) levels, tendon xanthomas, and premature coronary artery disease. Clinical diagnostic criteria include clinical findings, family history, or pathogenic mutations in the LDLR, APOB, or PCSK9. Proper suspicion of individuals with typical characteristics is essential for screening. Cascade screening is known to be the most efficient diagnostic approach. Early initiation of lipid-lowering therapy and the control of other risk factors are important. The first-line pharmacological treatment is statins, followed by ezetimibe, and PCSK9 inhibitors as required. The ideal treatment targets are 50% reduction and < 70 or < 55 mg/dL (in the presence of vascular disease) of LDL-C, although less strict targets are frequently used. Homozygous FH is characterized by untreated LDL-C > 500 mg/dL, xanthoma since childhood, and family history. In children, the diagnosis is made with criteria, including items largely similar to those of adults. In women, lipid-lowering agents need to be discontinued before conception. (Korean J Med 2022;97:339-352)

KCI후보

저자 : 안지현 ( Jihyun An )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 6호 발행 연도 : 2022 페이지 : pp. 353-360 (8 pages)

다운로드

(기관인증 필요)

초록보기

Chronic hepatitis B virus (HBV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma in Korea. While the prevalence of HBV infection is gradually declining in Korea, 3 of the population still suffers from HBV-related chronic liver diseases. In this review, we summarize the updated clinical guidelines for management of chronic HBV, as revised by the Korean Association for the Study of the Liver in 2022. (Korean J Med 2022;97:353-360)

KCI후보

저자 : 이신희 ( Shine Hee Lee ) , 강상범 ( Sang-bum Kang )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 6호 발행 연도 : 2022 페이지 : pp. 361-367 (7 pages)

다운로드

(기관인증 필요)

초록보기

KCI후보

저자 : 허란 ( Ran Heo )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 6호 발행 연도 : 2022 페이지 : pp. 368-374 (7 pages)

다운로드

(기관인증 필요)

초록보기

Evaluation of left ventricular diastolic function is essential, especially in patients with heart failure with preserved ejection fraction. The American Society of Echocardiography/European Association of Cardiovascular Imaging guidelines were released in 2016. Four principal parameters were used to assess left ventricular diastolic function. However, there are grey areas; the situation is complex. Recently, various other indicators have been employed to explore left ventricular diastolic function. (Korean J Med 2022;97:368-374)

KCI후보

저자 : 조형준 ( Hyeong Jun Cho ) , 이종민 ( Jongmin Lee ) , 이진국 ( Chin Kook Rhee ) , 김승준 ( Seung Joon Kim ) , 김석찬 ( Seok Chan Kim ) , 김영균 ( Young Kyoon Kim ) , 강지영 ( Ji Young Kang )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 6호 발행 연도 : 2022 페이지 : pp. 375-380 (6 pages)

다운로드

(기관인증 필요)

초록보기

The incidence of nontuberculous mycobacterial pulmonary disease is increasing, and Mycobacterium avium complex (MAC) is the most common causal species. Patients with underlying structural lung disease or an immunosuppressive condition are at increased risk for MAC infections. Endobronchial lesions caused by MAC infection are extremely rare, especially in immunocompetent hosts. Here, we describe a case of a 58-year-old woman with pulmonary infiltration and endobronchial involvement caused by MAC. The patient had shortness of breath and a productive cough. She had undergone surgery and chemoradiotherapy for lung cancer 10 years prior. Radiological findings revealed small centrilobular nodules with consolidation in the right lung and mild stenosis at the right main bronchus. Bronchoscopy revealed yellowish-white caseous necrosis in the right main bronchus. Mycobacterium intracellulare was identified in bronchial washing fluid. She was treated with antimicrobial medications. After 6 months of treatment, bronchial lesions, radiological findings, and symptoms had improved remarkably and she showed culture conversion. (Korean J Med 2022;97:375-380)

1
권호별 보기
같은 권호 수록 논문
| | | | 다운로드

KCI후보

저자 : 장현재 ( Hyun Jae Jang )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 3호 발행 연도 : 2022 페이지 : pp. 147-149 (3 pages)

다운로드

(기관인증 필요)

초록보기

노인장기요양보험 제도는 2005년부터 3년 동안 시범사업을 거쳐, 지난 2008년 7월부터 본격적으로 시행되었다. 이 제도의 목적은 증가되는 노인 인구에 있어, 노인의 삶의 질 개선과 가족의 돌봄 부담 경감이다. 2021년, 노인장기요양보험 수급자는 86만 명, 급여비는 9조 8,248억 원으로 도입된 이후 그 규모가 2-4배로 증가하였다. 이러한 증가에 맞추어 효율적으로 제도가 안착되고, 수급자의 의료적 요구를 바로 연계할 수 있는 제도의 보완이 필요하다. 이를 통하여 급증하는 노인 진료비의 지출의 감소, 즉 사회적 비용의 감소의 효과도 볼 수 있다. 결론적으로, 노인 돌봄은 의료·보건·복지가 각 영역 내 혹은 영역 간에 유기적으로 연계할 수 있도록 제대로 체계를 마련되고 시행되어야 하겠다.

KCI후보

저자 : 박용휘 ( Yongwhi Park ) , 허애영 ( Ae-young Her ) , 김현국 ( Hyun Kuk Kim ) , 문재연 ( Jae Youn Moon ) , 박재형 ( Jae Hyoung Park ) , 박근호 ( Keun-ho Park ) , 이경훈 ( Kyung Hoon Lee ) , 주형준 ( Hyung Joon Joo ) , 원호연 ( Ho Yeon Won ) , 안성균 ( Sung Gyun Ahn ) , 박홍준 ( Hong Jun Par

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 3호 발행 연도 : 2022 페이지 : pp. 150-168 (19 pages)

다운로드

(기관인증 필요)

초록보기

The prevalence of ischemic heart disease is steadily growing as populations age. Antithrombotic treatment is a key therapeutic modality for the prevention of secondary cerebro-cardiovascular disease. Patients with acute coronary syndrome or who are undergoing percutaneous coronary intervention must be treated with dual antiplatelet therapy for a mandatory period. The optimal perioperative antithrombotic regimen remains debatable; antithrombotics can cause bleeding. Inadequate antithrombotic regimens are associated with perioperative ischemic events, but continuation of therapy may increase the risks of perioperative hemorrhagic complications (including mortality). Many guidelines on the perioperative management of antithrombotic agents have been established by academic societies. However, the existing guidelines do not cover all specialties, nor do they describe the thrombotic and hemorrhagic risks associated with various surgical interventions. Moreover, few practical recommendations on the modification of antithrombotic regimens in patients who require non-deferrable interventions/surgeries or procedures associated with a high risk of hemorrhage have appeared. Therefore, cardiologists, specialists performing invasive procedures, surgeons, dentists, and anesthesiologists have not come to a consensus on optimal perioperative antithrombotic regimens. The Korean Platelet-Thrombosis Research Group presented a positioning paper on perioperative antithrombotic management. We here discuss commonly encountered clinical scenarios and engage in evidence-based discussion to assist individualized, perioperative antithrombotic management in clinical practice. (Korean J Med 2022;97:150-163)

KCI후보

저자 : 강화평 ( Huapyong Kang ) , 김의주 ( Eui Joo Kim ) , 김연석 ( Yeon Suk Kim )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 3호 발행 연도 : 2022 페이지 : pp. 164-170 (7 pages)

다운로드

(기관인증 필요)

초록보기

Malignant hilar biliary obstruction (MHBO) frequently accompanies cholestasis and cholangitis, and requires biliary stent placement. To prevent stent occlusion and prolong survival, local ablation therapy can be considered adjunctive to stent placement. Intraductal radiofrequency ablation (ID-RFA) is a recently developed local therapy for malignant biliary obstruction that can be easily performed employing endoscopic retrograde cholangiography. The use of ID-RFA to treat MHBO (as distinct from distal biliary obstruction) was suggested to be associated with severe adverse events. However, recent comparative studies have shown that ID-RFA is feasible and safe, and acceptably efficacious, in patients with advanced MHBO; newer temperature-controlled ID-RFA devices may enhance safety further. Regularly repeated ID-RFA with stent exchange affords better survival than stenting alone. However, the optimal ID-RFA strategy for MHBO remains inconclusive given the lack of data. Further large-scale clinical trials are needed. (Korean J Med 2022;97:164-170)

KCI후보

저자 : 송수현 ( Su Hyun Song ) , 최홍상 ( Hong Sang Choi ) , 배은희 ( Eun Hui Bae )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 3호 발행 연도 : 2022 페이지 : pp. 171-178 (8 pages)

다운로드

(기관인증 필요)

초록보기

Secondary hypertension, which refers to arterial hypertension caused by an identifiable medical condition, accounts for 5-10% of all hypertensive diagnoses; however, this is thought to be an underestimate. If diagnosed promptly, secondary hypertension can be treated, and proper blood pressure restored. This review focuses on the screening, diagnosis, and management of the most common forms of secondary hypertension, including primary aldosteronism, renovascular hypertension, pheochromocytoma, Cushing's syndrome, and renal parenchymal disease. (Korean J Med 2022;97:171-178)

KCI후보

저자 : 권재우 ( Jae-woo Kwon )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 3호 발행 연도 : 2022 페이지 : pp. 179-185 (7 pages)

다운로드

(기관인증 필요)

초록보기

Nitric oxide is produced by the human lungs and increases in response to type 2 inflammation. The level of fractional exhaled nitric oxide (FeNO) may reflect type 2 inflammation in the airways, which is related to eosinophilic inflammation and treatment responsiveness to corticosteroids. The FeNO test is a non-invasive, simple, and safe point-of-care test to evaluate airway inflammation. It has been standardized for clinical use and has been widely utilized in daily medical practice. However, various intrinsic and extrinsic factors can affect FeNO levels, and understanding and controlling such factors will improve the utility of this measure. The FeNO test can be used to confirm an asthma diagnosis, predict treatment responses to corticosteroids, and guide inhaled corticosteroid therapy for asthma treatment. (Korean J Med 2022;97:179-185)

KCI후보

저자 : 한정석 ( Jung Suk Han ) , 최범순 ( Bum Soon Choi ) , 박철휘 ( Cheol Whee Park ) , 최영진 ( Yeong Jin Choi ) , 양철우 ( Chul Woo Yang ) , 이한희 ( Han Hee Lee ) , 반태현 ( Tae Hyun Ban )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 3호 발행 연도 : 2022 페이지 : pp. 186-190 (5 pages)

다운로드

(기관인증 필요)

초록보기

크론병의 장관 외 발현 중 육아종성 세관사이질신염은 매우 드문 사례이다. 아직 정립된 치료는 없으나, 크론병 환자에서 신기능의 악화를 보인다면 크론병에 의한 세관사이질신염을 의심하여야 하며, 빠른 진단과 치료를 하여 환자의 신기능의 악화를 억제하여야 한다.

KCI후보

저자 : 오지홍 ( Ji Hong Oh ) , 홍승권 ( Seung Goun Hong )

발행기관 : 대한내과학회 간행물 : 대한내과학회지 (Korean J Med) 97권 3호 발행 연도 : 2022 페이지 : pp. 191-197 (7 pages)

다운로드

(기관인증 필요)

초록보기

Recurrent or refractory small bowel obstruction in postsurgical patients with advanced malignancies poses therapeutic dilemmas. Although some promising results have been achieved as small bowel endoscopic techniques advanced, palliative stent placement is both challenging and complex. Endoscopic ultrasound (EUS)-guided anastomosis using a lumen-apposing metal stent has been recently used during gastroenterostomy to treat benign or malignant gastric outlet obstruction. Data on the outcomes of EUS-guided enterostomy in patients with recurrent small bowel obstruction are lacking, although the technique is applicable throughout the entire gastrointestinal tract. We recently encountered recurrent or refractory small bowel obstruction in two poor surgical candidates. For the first case, we performed EUS-guided enterostomy to treat a recurrent obstruction after conventional stent insertion. The second case underwent EUS-guided transenteric stent placement to treat refractory small bowel obstruction associated with diffuse peritoneal carcinomatosis after failure of a conventional “push” endoscopic procedure. (Korean J Med 2022;97:191-197)

1

내가 찾은 최근 검색어

최근 열람 자료

맞춤 논문

보관함

내 보관함
공유한 보관함

1:1문의

닫기